Consensus Bastide Le Confort Médical London S.E.

Equities

0IP1

FR0000035370

Market Closed - London S.E. Other stock markets 09:00:39 16/04/2024 pm IST			5-day change	1st Jan Change
15.62 ^EUR	-54.92%		-21.90%	-41.49%

15/05	BASTIDE LE CONFORT MEDICAL : De facto maintained guidance; more disposals to propel debt reduction
15/05	Bastide: 8.2% increase in quarterly sales	CF

Evolution of the average Target Price on Bastide Le Confort Médical

Price target over the last 5 years

History of analyst recommendation changes

32720069635bd8e970255a86d.uM2mcrowgch5aYmOMfObSA9F0EBOkewVltW2hiaGZwU.1Z7OQv8B9JFMM8fmZauue0QrpBY43qNGx7nFwXPEP1faiN5B23LAnC4q-g~189e3572b9a8bf339d1a05d84b031ded

Analyst Recommendations on Bastide Le Confort Médical

BASTIDE LE CONFORT MEDICAL : De facto maintained guidance; more disposals to propel debt reduction	16/05
BASTIDE LE CONFORT MEDICAL : EPS upgrade (2023: 0.0%, 2024: +1.6%)	09/04
BASTIDE LE CONFORT MEDICAL : The prioritised debt reduction awaits further visible progress	21/03
BASTIDE LE CONFORT MEDICAL : Reiterated guidance and further progress on the in debt profile	15/02
BASTIDE LE CONFORT MEDICAL : Reconfirmed outlook and early progress in debt profile improvement	19/11
BASTIDE LE CONFORT MEDICAL : Target cut by -29.6%	20/23/20
BASTIDE LE CONFORT MEDICAL : Debt reduction is the first priority, followed by expansion	19/23/19
ODDO BHF Reaffirms Bastide Le Confort Médical at Outperform, Trims PT	31/23/31	MT
BASTIDE : Oddo BHF lowers its target price	31/23/31	CF
BASTIDE LE CONFORT MEDICAL : Mediocre Q4 revenues but normalisation expected; outlook unchanged	30/23/30
BASTIDE LE CONFORT MEDICAL : Decent Q3 revenues; outlook unchanged	16/23/16
BASTIDE LE CONFORT MEDICAL : Improving profitability and cash generation; outlook unchanged	24/23/24
BASTIDE LE CONFORT MEDICAL : Well-received H1 revenue; broadly unchanged outlook	17/23/17
BASTIDE LE CONFORT MEDICAL : A (too?) prudent margin forecast	20/22/20
BASTIDE LE CONFORT MEDICAL : More international, more specialised	31/22/31
BASTIDE LE CONFORT MEDICAL : Steady growth and active M&As should continue	12/22/12
BASTIDE LE CONFORT MEDICAL : Active M&As on the table	23/22/23
BASTIDE LE CONFORT MEDICAL : Reiterated FY guidance	08/22/08
BASTIDE LE CONFORT MEDICAL : Following the allegations of false billing	31/22/31
BASTIDE LE CONFORT MEDICAL : Flat Q1 trading, outlook reconfirmed	16/21/16
BASTIDE LE CONFORT MEDICAL : Prudent outlook hoping to be uplifted by M&A	19/21/19
BASTIDE LE CONFORT MEDICAL : FY revenue beat guidance	06/21/06
BASTIDE LE CONFORT MEDICAL : H1 margin in line	26/21/26
BASTIDE LE CONFORT MEDICAL : Supportive H1 sales, upbeat FY guidance	12/21/12